Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATITA: Anti-inflammatory Treatment for Inactive Takayasu Arteritis
NCT03550781Phase 3Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jun 2018
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of prednisone, cyclophosphamide in Takayasu arteritis (TAK), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
prednisonecyclophosphamide
03
Conditions
Takayasu arteritis (TAK)
Beyond the preview
Go deeper on NCT03550781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03550781.